GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » Cyclically Adjusted Book per Share

ResMed (BSP:R1MD34) Cyclically Adjusted Book per Share : R$0.00 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is ResMed Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ResMed's adjusted book value per share for the three months ended in Mar. 2024 was R$39.188. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, ResMed's average Cyclically Adjusted Book Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of ResMed was 32.00% per year. The lowest was 6.90% per year. And the median was 16.50% per year.

As of today (2024-04-29), ResMed's current stock price is R$278.16. ResMed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was R$0.00. ResMed's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.26. And the median was 8.53.


ResMed Cyclically Adjusted Book per Share Historical Data

The historical data trend for ResMed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Cyclically Adjusted Book per Share Chart

ResMed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 12.62 18.50 20.86 24.50

ResMed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.75 24.50 37.16 22.78 -

Competitive Comparison of ResMed's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, ResMed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's Cyclically Adjusted PB Ratio falls into.



ResMed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ResMed's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=39.188/129.4194*129.4194
=39.188

Current CPI (Mar. 2024) = 129.4194.

ResMed Quarterly Data

Book Value per Share CPI Adj_Book
201406 7.005 100.560 9.015
201409 6.914 100.428 8.910
201412 7.473 99.070 9.762
201503 8.566 99.621 11.128
201506 8.790 100.684 11.299
201509 10.215 100.392 13.169
201512 10.564 99.792 13.700
201603 11.022 100.470 14.198
201606 10.312 101.688 13.124
201609 10.232 101.861 13.000
201612 10.126 101.863 12.865
201703 10.229 102.862 12.870
201706 11.359 103.349 14.224
201709 11.282 104.136 14.021
201712 11.642 104.011 14.486
201803 11.872 105.290 14.593
201806 13.605 106.317 16.561
201809 13.698 106.507 16.645
201812 13.254 105.998 16.183
201903 13.539 107.251 16.338
201906 13.904 108.070 16.651
201909 15.167 108.329 18.120
201912 16.024 108.420 19.128
202003 19.054 108.902 22.644
202006 22.355 108.767 26.600
202009 24.957 109.815 29.412
202012 25.325 109.897 29.824
202103 26.229 111.754 30.375
202106 24.907 114.631 28.120
202109 27.408 115.734 30.649
202112 30.417 117.630 33.466
202203 27.889 121.301 29.756
202206 28.967 125.017 29.987
202209 30.726 125.227 31.755
202212 33.369 125.222 34.488
202303 34.853 127.348 35.420
202306 34.076 128.729 34.259
202309 35.679 129.860 35.558
202312 37.325 129.419 37.325
202403 39.188 129.419 39.188

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


ResMed  (BSP:R1MD34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.26. And the median was 8.53.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ResMed Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of ResMed's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed (BSP:R1MD34) Business Description

Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (BSP:R1MD34) Headlines

No Headlines